Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

The old timers on IV sometimes have rose

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sts66 Member Profile
 
Followed By 23
Posts 3,855
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Navidea Biopharmaceuticals to Present at the 2014 LD Micro Conference "Business Wire" - 11/25/2014 7:30:00 AM
European Commission Approves Navidea’s Sentinel Lymph Node Detection Agent Lymphoseek® "Business Wire" - 11/20/2014 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/17/2014 4:36:09 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/14/2014 4:05:25 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2014 2:04:49 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:39:03 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:36:26 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:20:39 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:18:19 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:09:37 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 11:05:45 AM
Navidea Receives $1.1Million PDUFA Filing Fee Refund for Award of Orphan Drug Status; Platinum Partners Reaffirms Commitment ... "Business Wire" - 11/11/2014 7:30:00 AM
Navidea Announces Third Quarter 2014 Financial Results "Business Wire" - 11/6/2014 7:30:00 AM
Navidea Announces Scientific Presentations of Results from Lymphoseek® Studies at the European Association of Nuclear Medici... "Business Wire" - 10/30/2014 7:30:00 AM
Navidea Biopharmaceuticals to Announce Third Quarter 2014 Financial Results on November 6, 2014 "Business Wire" - 10/29/2014 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/16/2014 5:25:31 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/15/2014 4:45:59 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 10/15/2014 4:03:40 PM
Navidea Announces Rick Gonzalez as New Chief Executive Officer "Business Wire" - 10/15/2014 8:00:00 AM
FDA Approves Expanded Use of Navidea’s Lymphoseek® for Lymphatic Mapping in Solid Tumors "Business Wire" - 10/15/2014 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/8/2014 4:05:27 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/1/2014 1:05:05 PM
Navidea to Participate in the BTIG Emerging Technologies in Healthcare Diagnostics Investor Conference September 30th "Business Wire" - 9/29/2014 3:36:00 PM
Navidea’s Lymphoseek® Recommended by CHMP for European Approval in Sentinel Lymph Node Detection for Melanoma, Breast & Ce... "Business Wire" - 9/26/2014 7:27:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/24/2014 4:40:16 PM
sts66   Wednesday, 04/24/13 08:06:49 PM
Re: hondadriver1973 post# 3569
Post # of 7411 
The old timers on IV sometimes have rose colored glasses on....they refuse to see manipulation.....being shorted by firms supposedly investing in NAVB....even the words "basher" or similar are not allowed by DDB....this just doesn't smell right to me.....and JPM apparently bought some for a 2nd unnamed investor again, same thing as last time....who are these mystery buyers and why are their names being kept a secret?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist